C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 35/00 (2006.01) C07D 487/08 (2006.01)
Patent
CA 2691417
Disclosed are the ERK inhibitors of formula 1.0: [Formula (1.0)] and the pharmaceutically acceptable salts, esters and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1Ø
L'invention concerne des inhibiteurs d'ERK représentés par la formule 1.0 : [Formule (1.0)] et des sels, des esters et des solvates pharmaceutiquement acceptables de ceux-ci. Q est un cycle pipéridine ou pipérazine susceptible de posséder un pont ou un cycle condensé. Le cycle pipéridine peut comporter une double liaison. Tous les autres substituants sont tels que définis ici. L'invention concerne également des procédés destinés à traiter le cancer utilisant les composés représentés par la formule 1Ø
Boga Sobhana Babu
Cooper Alan B.
Deng Yongqi
Doll Ronald J.
Gao Xiaolei
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Schering Corporation
LandOfFree
Heterocyclic compounds and use thereof as erk inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds and use thereof as erk inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds and use thereof as erk inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1901982